Dr. Alexan Isahag Yerevanian, MD

Dr. Yerevanian practices at Lovelace Medical Group in Albuquerque, New Mexico.

Dr. Yerevanian's NPI, 1114301637, was assigned on July 14, 2015. Dr. Yerevanian graduated from Cleveland Medical College, Homeopathic in 2015. Dr. Yerevanian's California license number on file is 143798.

Dr. Yerevanian's primary practice is Lovelace Medical Group, at 4101 Indian School NE Rd, Albuquerque, NM 87110 in Bernalillo County. The practice phone is (505) 727-6200.

Dr. Yerevanian's primary practice is Lovelace Medical Group in Albuquerque, New Mexico. Dr. Yerevanian is also affiliated with Lovelace Medical Center. The medical group on file is Lovelace Medical Group. Dmand AI also links Dr. Yerevanian to 5 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yerevanian practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Yerevanian's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Yerevanian is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Yerevanian's licenses on file in 2 states: California and New Mexico.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Yerevanian treats.

CMS data shows 2,102 Medicare services from Dr. Yerevanian across 10 procedure codes in 2024, for 487 Medicare patients. Medicare paid $162,240 for them.

CMS counts 487 Medicare patients who saw Dr. Yerevanian in 2024. The largest group is 75 to 84, with 190 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yerevanian's median patient age at 70, with 64% women.

In 2024, Dr. Yerevanian wrote 1,786 Medicare Part D claims for 375 patients. 89% of them were for generic drugs. CMS names the drug for 1,478 of them, across 40 drugs with 11 or more claims each, at $822,405 in total drug cost. In 2023, CMS named 1,528 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Yerevanian for performance year 2024, reported as part of a group. Dr. Yerevanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yerevanian as offering telehealth.

Dmand AI links 7 papers to Dr. Yerevanian, published from 2010 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Genetic Therapy and Heart Failure. Dr. Yerevanian's most frequent co-authors are Fanny Huynh Du, MD, Richard M. Ransohoff, MD and Matthew Shtrahman, MD.

CMS Open Payments shows 232 general payments to Dr. Yerevanian from 40 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $1,534.

Dr. Yerevanian graduated from Cleveland Medical College, Homeopathic in 2015.

Dr. Yerevanian is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.